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The function of human myeloid derived suppressor cells
(MDSCs) cannot be precisely measured without the
proper identification of homogeneous populations. Indeed,
many published accounts of human MDSCs are really
describing multiple distinct populations confused either by
sample processing, poor gating strategies, and/or lack of
appropriate cell surface markers. To improve the standar-
dization of the identification of human myeloid derived
suppressor cells and other myeloid phenotypes, we devel-
oped a method for the identification and analysis of
human myeloid populations by the use of several 10-color
flow cytometric protocols in combination with novel soft-
ware analyses. This method utilizes the direct staining of
peripheral blood that allows for the quantitation of
myeloid cells and the delineation of non-overlapping
immunophenotypes. The 10-color protocols, tested in
both healthy volunteer controls and cancer patients, allow
us to define diverse phenotypes that include mature
monocytes, granulocytes, circulating dendritic cells, imma-
ture myeloid cells, in addition to MDSCs. We demonstrate
that human MDSC subsets fall into three distinct
populations: CD14+HLA-DRlo/neg monocytes, LIN-CD33
+HLA-DR- cells, and CD15+ granulocytes. We additionally
identify CD123 as a marker uniquely expressed on LIN-
CD33+HLA-DR- MDSCs. Our method permits us to
measure myeloid and MDSC phenotypes in relation to
total mononuclear cells, total myeloid cells, total leuko-
cytes and as cell counts. The data generated from our
method will allow for more uniform reporting of myeloid
and MDSC phenotypes for biomarker development.
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